Teva Pharmaceutical Industries (TEVA) Net Income - Minority: 2009-2025
Historic Net Income - Minority for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to -$4.0 million.
- Teva Pharmaceutical Industries' Net Income - Minority rose 98.75% to -$4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.0 million, marking a year-over-year increase of 98.75%. This contributed to the annual value of -$7.0 million for FY2024, which is 98.87% up from last year.
- Teva Pharmaceutical Industries' Net Income - Minority amounted to -$4.0 million in Q3 2025, which was up 42.86% from -$7.0 million recorded in Q2 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Net Income - Minority registered a high of -$4.0 million during Q3 2025, and its lowest value of -$987.0 million during Q2 2021.
- In the last 3 years, Teva Pharmaceutical Industries' Net Income - Minority had a median value of -$265.0 million in 2024 and averaged -$311.1 million.
- As far as peak fluctuations go, Teva Pharmaceutical Industries' Net Income - Minority fell by 1.54% in 2021, and later skyrocketed by 98.87% in 2024.
- Teva Pharmaceutical Industries' Net Income - Minority (MRQ) stood at -$966.0 million in 2021, then rose by 17.81% to -$794.0 million in 2022, then increased by 21.91% to -$620.0 million in 2023, then soared by 98.87% to -$7.0 million in 2024, then surged by 42.86% to -$4.0 million in 2025.
- Its Net Income - Minority was -$4.0 million in Q3 2025, compared to -$7.0 million in Q2 2025 and -$7.0 million in Q1 2025.